Theravance Biopharma Inc (0TB) — Net Asset Momentum
Theravance Biopharma Inc (0TB) recorded a net asset momentum of -17.6% as of December 2024, with net assets of €175.54 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Theravance Biopharma Inc (0TB) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Theravance Biopharma Inc Net Asset Momentum (2014–2024)
This chart tracks Theravance Biopharma Inc's year-over-year net asset growth across 11 annual reporting periods from 2014 to 2024. The most recent momentum reading is -17.6%, with net assets of €175.54 Million EUR as of December 2024. For live market cap and overall valuation, see how much is Theravance Biopharma Inc worth.
Annual Net Asset History for Theravance Biopharma Inc (2014–2024)
The table below shows the complete annual net asset history for Theravance Biopharma Inc from 2014 to 2024, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Theravance Biopharma Inc's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €175.54 Million | €354.16 Million | €178.62 Million | ▼ -17.6% |
| 2023 | €213.00 Million | €382.00 Million | €169.00 Million | ▼ -51.8% |
| 2022 | €441.80 Million | €607.40 Million | €165.60 Million | ▲ +230.5% |
| 2021 | €-338.57 Million | €374.82 Million | €713.39 Million | ▼ -11.5% |
| 2020 | €-303.75 Million | €469.06 Million | €772.81 Million | ▼ -35.7% |
| 2019 | €-223.84 Million | €408.83 Million | €632.67 Million | ▼ -333.9% |
| 2018 | €-51.59 Million | €560.24 Million | €611.82 Million | ▼ -144.8% |
| 2017 | €115.18 Million | €441.40 Million | €326.22 Million | ▼ -67.1% |
| 2016 | €350.23 Million | €639.25 Million | €289.02 Million | ▲ +44.1% |
| 2015 | €243.06 Million | €300.12 Million | €57.05 Million | ▼ -16.1% |
| 2014 | €289.79 Million | €337.77 Million | €47.98 Million | — |